Accueil   Diary - News   All news Focus on Cellipse

Focus on Cellipse


Cellipse is a company member of Lyonbiopole based in Grenoble. It was created in early 2013 by three co- founders: Dr. Laurence Lafanechère , Dr Renaud Prudent and Fabrice Paublant . They rely on internal know- how in the high content phenotypic screening and optimizing small molecule lead. The co- founders of CELLIPSE are trying to build a company Biotech leader in the field of small agents cytoskeletal regulatory molecules with application in oncology and beyond ( Central Nervous System , Eyesight ... ) . CELLIPSE and Albert Bonniot Institute , Grenoble won the Proof of Concept Competition 2013 Cancéropôle CLARA .



Cellipse just joined the Board of Directors of the pole for 2 years , as a non-permanent member and representative of the business college. This SME Drug Discovery aims to bring innovative therapies to patients with cancer. She develops a portfolio of small molecules targeting the cytoskeleton ( microtubules and actin ) based on its approach "cell to drug discovery ." It will be part of the Rhône-Alpes Lyonbiopôle delegation that will accompany BIO San Diego from 23 to 26 June.